Longitudinal Effects of Medication Nonadherence on Glycemic Control
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Background: Medication nonadherence is known to worsen glycemic control. Few studies have examined this relationship over several years. Objective: The aim of this study was to examine the longitudinal effect of medication nonadherence on glycemic control among a large cohort of veterans. Methods: Analysis was performed on a cohort of 11 272 veterans with type 2 diabetes followed from April 1994 to May 2006. The primary outcome measures were mean glycosylated hemoglobin A1c (A1C) and proportion in poor control (A1C > 8%) over time. The main predictor was medication nonadherence based on medication possession ratio (MPR). Other covariates included sociodemographics and ICD-9 coded medical and psychiatric comorbidities. Generalized linear mixed models (GLMMs) were used to assess the relationship between MPR and A1C after adjusting for covariates. Results: Mean follow-up was 5.4 years. In the linear mixed model, after adjusting for baseline A1C and other confounding variables, mean A1C decreased by 0.24 ( P < 0.001) for each 10% increase in MPR (95% CI = −0.27, −0.21). In the fully adjusted GLMM, each percentage increase in MPR was associated with a 48% lower likelihood of having poor glycemic control (odds ratio = 0.52; 95% CI = 0.4, 0.6). In both continuous and dichotomized A1C analyses, average A1C showed a decreasing trend over the study period ( P < 0.001). Conclusions: In patients with type 2 diabetes, glycemic control worsens over time in the presence of medication nonadherence. Future studies need to take into account the complexity of patient- and system-level factors affecting long-term medication adherence to improve diabetes-related outcomes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Suboptimal medication-taking behavior and low rates of continued medication use, or what is termed ' persistence to therapy plans, ' affects almost half of people with type 2 diabetes, leading to suboptimal glycemic and CVD risk factor control as well as increased risks of diabetes complications, mortality, and hospital admissions and increased health care costs (58 -62).”
In the citing paper
“Suboptimal medication-taking behavior and low rates of continued medication use, or what is termed ' persistence to therapy plans, ' affects almost half of people with type 2 diabetes, leading to suboptimal glycemic and CVD risk factor control as well as increased risks of diabetes complications, mortality, and hospital admissions and increased health care costs (58 -62).”
Citations
Cites
Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data
Quan, H., Sundararajan, V., Halfon, P., Fong, A., Burnand, B., Luthi, J.-C., Saunders, L. D., Beck, C. A., Feasby, T. E., & Ghali, W. A. (2005) · Medical Care · doi:10.1097/01.mlr.0000182534.19832.83 · Cited by 10,669
Diggle, P. J., Heagerty, P. J., Liang, K.-Y., & Zeger, S. L. (2002) · doi:10.1093/oso/9780198524847.001.0001 · Cited by 3,384
Ho, P. M., Rumsfeld, J. S., Masoudi, F. A., McClure, D. L., Plomondon, M. E., Steiner, J. F., & Magid, D. J. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.17.1836 · Cited by 1,135
Farmer, K. C. (1999) · Clinical Therapeutics · doi:10.1016/s0149-2918(99)80026-5 · Cited by 889
Lee, J. K., Grace, K. A., & Taylor, A. J. (2006) · JAMA · doi:10.1001/jama.296.21.joc60162 · Cited by 807
Hess, L. M., Raebel, M. A., Conner, D. A., & Malone, D. C. (2006) · Annals of Pharmacotherapy · doi:10.1345/aph.1h018 · Cited by 756
Missing data methods in longitudinal studies: a review
Ibrahim, J. G., & Molenberghs, G. (2009) · TEST · doi:10.1007/s11749-009-0138-x · Cited by 512
Miller, D. R., Safford, M. M., & Pogach, L. M. (2004) · Diabetes Care · doi:10.2337/diacare.27.suppl_2.b10 · Cited by 425
Clinical Outcomes and Adherence to Medications Measured by Claims Data in Patients With Diabetes
Pladevall, M., Williams, L. K., Potts, L. A., Divine, G., Xi, H., & Elston Lafata, J. (2004) · Diabetes Care · doi:10.2337/diacare.27.12.2800 · Cited by 404
The association between diabetes metabolic control and drug adherence in an indigent population
Schectman, J. M., Nadkarni, M. M., & Voss, J. D. (2002) · Diabetes Care · doi:10.2337/diacare.25.6.1015 · Cited by 373 · cited 1×
“Similar findings have been reported in other studies with rural, indigent, and commercially insured patients.(7,12) However, treatment intensity was significantly less despite having worse metabolic control.”
ResultLau, D. T., & Nau, D. P. (2004) · Diabetes Care · doi:10.2337/diacare.27.9.2149 · Cited by 318
Piette, J. D., Wagner, T. H., Potter, M. B., & Schillinger, D. (2004) · Medical Care · doi:10.1097/01.mlr.0000108742.26446.17 · Cited by 293
Heisler, M. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.17.1853 · Cited by 237
Conn, V. S., Hafdahl, A. R., Cooper, P. S., Ruppar, T. M., Mehr, D. R., & Russell, C. L. (2009) · The Gerontologist · doi:10.1093/geront/gnp037 · Cited by 227
Grant, R., Adams, A. S., Trinacty, C. M., Zhang, F., Kleinman, K., Soumerai, S. B., Meigs, J. B., & Ross-Degnan, D. (2007) · Diabetes Care · doi:10.2337/dc06-2170 · Cited by 218
Vijan, S., Hayward, R. A., Ronis, D. L., & Hofer, T. P. (2005) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2005.0117.x · Cited by 202
Karve, S., Cleves, M. A., Helm, M., Hudson, T. J., West, D. S., & Martin, B. C. (2008) · Medical Care · doi:10.1097/mlr.0b013e31817924d2 · Cited by 176
Lindenmeyer, A., Hearnshaw, H., Vermeire, E., Royen, P. V., Wens, J., & Biot, Y. (2006) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2006.00759.x · Cited by 166
Yang, Y., Thumula, V., Pace, P. F., Banahan, B. F., Wilkin, N. E., & Lobb, W. B. (2009) · Clinical Therapeutics · doi:10.1016/j.clinthera.2009.10.002 · Cited by 155
Race and medication adherence in Medicaid enrollees with type-2 diabetes.
Shenolikar, R. A., Balkrishnan, R., Camacho, F., Whitmire, J. T., & Anderson, R. T. (2006) · PubMed · Cited by 135
The Influence of Insulin Use on Glycemic Control
Cramer, J. A., & Pugh, M. J. (2005) · Diabetes Care · doi:10.2337/diacare.28.1.78 · Cited by 134
Medication Adherence and Racial Differences in A1C Control
Adams, A. S., Trinacty, C. M., Zhang, F., Kleinman, K., Grant, R. W., Meigs, J. B., Soumerai, S. B., & Ross‐Degnan, D. (2008) · Diabetes Care · doi:10.2337/dc07-1924 · Cited by 127
Factors Influencing Disease Self-Management Among Veterans with Diabetes and Poor Glycemic Control
Nelson, K. M., McFarland, L., & Reiber, G. (2007) · Journal of General Internal Medicine · doi:10.1007/s11606-006-0053-8 · Cited by 112 · cited 1×
“Medication nonadherence, generally defined as taking <80% of prescribed medications, is also a major factor in poor diabetes self-care.(4,5) The literature reports that several factors are related to medication nonadherence among people with type 2 diabetes, including sociodemographic factors,(1,6-9) longer diabetes d…”
BackgroundBézie, Y., Molina, M. I., Hernández, N., Batista, R., Niang, S. D., & Huet, D. (2006) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70316-6 · Cited by 106
Data Resources in the Department of Veterans Affairs
Maynard, C., & Chapko, M. K. (2004) · Diabetes Care · doi:10.2337/diacare.27.suppl_2.b22 · Cited by 99
Depression in Patients with Type 2 Diabetes: Impact on Adherence to Oral Hypoglycemic Agents
Kalsekar, I. D., Madhavan, S., Amonkar, M. M., Makela, E. H., Scott, V., Douglas, S. M., & Elswick, B. M. (2006) · Annals of Pharmacotherapy · doi:10.1345/aph.1g606 · Cited by 90
Adherence to diabetes self-care behaviors in English- and Spanish-speaking Hispanic men
Rustveld, L. O., Pavlik, V., Jibaja‐Weiss, M. L., Kline, K. N., Gossey, T., & Volk, R. J. (2009) · Patient Preference and Adherence · doi:10.2147/ppa.s5383 · Cited by 61
Adherence to Oral Therapy for Type 2 Diabetes: Opportunities for Enhancing Glycemic Control
Bartels, D. (2004) · Journal of the American Academy of Nurse Practitioners · doi:10.1111/j.1745-7599.2004.tb00366.x · Cited by 40
Diabetes Mellitus Medication Assistance Program: Relationship of Effectiveness to Adherence
Horswell, R. L., Wascom, C. K., Cerise, F. P., Besse, J. A., & Johnson, J. K. (2008) · Journal of Health Care for the Poor and Underserved · doi:10.1353/hpu.0.0062 · Cited by 24
Research works printed but not linked: 2
- Shenolikar RA, 2006, J Natl Med Assoc, 98, 1071
- Hunt J, 2009, Manag Care, 18, 47
Cited by
Davies, M. J., D’Alessio, D. A., Fradkin, J., Kernan, W. N., Mathieu, C., Mingrone, G., Rossing, P., Tsapas, A., Wexler, D. J., & Buse, J. B. (2018) · Diabetes Care · doi:10.2337/dci18-0033 · Cited by 3,518
Davies, M. J., Aroda, V. R., Collins, B. S., Gabbay, R. A., Green, J., Maruthur, N. M., Rosas, S. E., Del Prato, S., Mathieu, C., Mingrone, G., et al. (2022) · Diabetes Care · doi:10.2337/dci22-0034 · Cited by 2,104
Davies, M. J., D’Alessio, D. A., Fradkin, J., Kernan, W. N., Mathieu, C., Mingrone, G., Rossing, P., Tsapas, A., Wexler, D. J., & Buse, J. B. (2018) · Diabetologia · doi:10.1007/s00125-018-4729-5 · Cited by 1,455
Davies, M. J., Aroda, V. R., Collins, B. S., Gabbay, R. A., Green, J., Maruthur, N. M., Rosas, S. E., Del Prato, S., Mathieu, C., Mingrone, G., et al. (2022) · Diabetologia · doi:10.1007/s00125-022-05787-2 · Cited by 1,048
Polonsky, W., & Henry, R. (2016) · Patient Preference and Adherence · doi:10.2147/ppa.s106821 · Cited by 784
“Among them, it is evident that poor medication adherence looms large.(16) This article reviewed the magnitude of the problem of poor medication adherence, the impact of poor adherence on long-term outcomes and health care costs, and the key contributors to poor medication adherence.”
Influential
Metadata
- Authors
- Egede, L. E., Gebregziabher, M., Echols, C., & Lynch, C. P.
- Affiliations
- Medical University of South Carolina (US)
- United States Department of Labor (US)
- Venue
- Annals of Pharmacotherapy
- Publisher
- SAGE Publications
- Published
- 2014-02-28
- Volume
- 48
- Issue
- 5
- Pages
- 562-570
- ISSN
- 0012-6578 (ISSN-L)
- 1060-0280
- 1542-6270
- OpenAlex
- W2120271909
- Cited by
- 146
- References
- 29
- Citations by year
- 2026: 1 · 2025: 10 · 2024: 15 · 2023: 19 · 2022: 16 · 2021: 21 · 2020: 9 · 2019: 12 · 2018: 14 · 2017: 12 · 2016: 9 · 2015: 6 · 2014: 2
- FWCI
- 9.92
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Annals of Pharmacotherapy (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- medication non-adherence, glycemic control, type 2 diabetes, medication possession ratio, glycosylated hemoglobin A1c, veterans, longitudinal effects, poor glycemic control
- MeSH terms
- Aged, Diabetes Mellitus, Type 2, Female, Glycated Hemoglobin, Humans, Hypoglycemic Agents, Male, Middle Aged, Veterans, Linear Models, Drug Monitoring
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.